First Choice Healthcare Solutions, Inc. (FCHS): EBITDA
-$2.65M
Year ended 2025-12-31
-$2.77M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$2.65M | n/m | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | -$1.25M | n/m | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | -$2.37M | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$6.93M | n/a | 2024-05-13, From 2022-01-01 |
| No annual figure between 2017-12-31 and 2022-12-31. | |||
| 2017-12-31 | -$3.47M | n/m | 2018-04-03, From 2017-01-01 |
| 2016-12-31 | $961.4K | n/m | 2018-04-03, From 2016-01-01 |
| 2015-12-31 | -$1.08M | n/m | 2017-04-03, From 2015-01-01 |
| 2014-12-31 | -$991.0K | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$459.5K | n/m | 2015-04-15, From 2013-01-01 |
| 2012-12-31 | $32.2K | n/m | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | -$6.16M | n/a | 2013-04-01, From 2011-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | -$2.65M | n/m |
| Aclarion, Inc. (ACON) | 2025-12-31 | -$6.82M | n/m |
| American Shared Hospital Services (AMS) | 2025-12-31 | $2.13M | -36.9% |
| Exagen Inc. (XGN) | 2025-12-31 | -$11.97M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$22.20M | n/m |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | -$35.56M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | -$78.01M | n/m |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$15.76M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$2.04M | n/m |
Compare FCHS, ACON, AMS, XGN side by side · Screen every company in Services-Medical Laboratories ↗